A word from the founder
Watch Video
A word from the founder
Watch Video
Revolution in cancer
prevention theranostics & AI
Revolution in
cancer prevention theranostics & AI
Revolution in
cancer prevention theranostics & AI
Revolution in cancer
prevention theranostics & AI
Revolution in
cancer prevention theranostics & AI
Alercell growth is fueled by internal research and alliances and the passion of our CEO for genetics and Artificial Intelligence!
Alercell growth is fueled by internal research and alliances and the passion of our CEO for genetics and Artificial Intelligence!
Alercell growth is fueled by internal research and alliances and the passion of our CEO for genetics and Artificial Intelligence!
Alercell growth is fueled by internal research and alliances and the passion of our CEO for genetics and Artificial Intelligence!
A word from the founder
Watch Video
Revolution in cancer
prevention theranostics & AI
Alercell growth is fueled by internal research and alliances and the passion of our CEO for genetics and Artificial Intelligence!
Alercell is a true innovator, disruptor, and leader in the field of preventative oncology. Committed to making a difference in the fight against cancer and Leukemia.
Alercell is a true innovator, disruptor, and leader in the field of preventative oncology. Committed to making a difference in the fight against cancer and Leukemia.
Alercell is a true innovator, disruptor, and leader in the field of preventative oncology. Committed to making a difference in the fight against cancer and Leukemia.
Alercell is a true innovator, disruptor, and leader in the field of preventative oncology. Committed to making a difference in the fight against cancer and Leukemia.
Alercell is a true innovator, disruptor, and leader in the field of preventative oncology. Committed to making a difference in the fight against cancer and Leukemia.
Our Service
Early Genetic
Detection
Early Genetic
Detection
Early Genetic
Detection
Early Genetic
Detection
Alercell, Inc. aims to streamline the process for testing of cancer and Leukemia in developing cancer testing technology through very early genetic detection.
Leukemia
LENA Q51® by Alercell is detecting 51 genes mutation thus a very significant technological and medical advance.
Cancer
Leukemia
LENA Q51® by Alercell is detecting 51 genes mutation thus a very significant technological and medical advance.
Cancer
Leukemia
LENA Q51® by Alercell is detecting 51 genes mutation thus a very significant technological and medical advance.
Cancer
Leukemia
LENA Q51® by Alercell is detecting 51 genes mutation thus a very significant technological and medical advance.
Cancer
Leukemia
LENA Q51® by Alercell is detecting 51 genes mutation thus a very significant technological and medical advance.
Cancer
Leukemia
LENA Q51® by Alercell is detecting 51 genes mutation thus a very significant technological and medical advance.
Cancer
Technology
AI for precise
biomarkers
AI for precise
biomarkers
AI for precise
biomarkers
AI for precise
biomarkers
Alercell leverages AI to develop more precise and targeted biomarkers for the earliest possible detection of cancer. Driven by advanced methodologies.
Our Diagnostics
Our Diagnostics
Our Diagnostics
Our Diagnostics
The Alercell mission is built on the foundation of “stopping it before it starts”.
The Alercell mission is built on the foundation of “stopping it before it starts”.
The Alercell mission is built on the foundation of “stopping it before it starts”.
The Alercell mission is built on the foundation of “stopping it before it starts”.
LENA Q51®
The Alercell mission is built on the foundation of “stopping it before it starts”.
LENA S1
Lena S1 aims to enable pre-symptomatic and precise identification of lung cancer, providing a vital tool for improving survival rates and reducing diagnostic errors.
LENA Molecular Dx Leukemia Platform
Breakthrough technology of Alercell-Oncology.
Alercell is now a One-Stop-Shop for all Leukemia tests.
LENA Q51®
The Alercell mission is built on the foundation of “stopping it before it starts”.
LENA S1
Lena S1 aims to enable pre-symptomatic and precise identification of lung cancer, providing a vital tool for improving survival rates and reducing diagnostic errors.
LENA Molecular Dx Leukemia Platform
Breakthrough technology of Alercell-Oncology.
Alercell is now a One-Stop-Shop for all Leukemia tests.
LENA Q51®
The Alercell mission is built on the foundation of “stopping it before it starts”.
LENA S1
Lena S1 aims to enable pre-symptomatic and precise identification of lung cancer, providing a vital tool for improving survival rates and reducing diagnostic errors.
LENA Molecular Dx Leukemia Platform
Breakthrough technology of Alercell-Oncology.
Alercell is now a One-Stop-Shop for all Leukemia tests.
LENA Q51®
The Alercell mission is built on the foundation of “stopping it before it starts”.
LENA S1
Lena S1 aims to enable pre-symptomatic and precise identification of lung cancer, providing a vital tool for improving survival rates and reducing diagnostic errors.
LENA Molecular Dx Leukemia Platform
Breakthrough technology of Alercell-Oncology.
Alercell is now a One-Stop-Shop for all Leukemia tests.
LENA Q51®
The Alercell mission is built on the foundation of “stopping it before it starts”.
LENA S1
Lena S1 aims to enable pre-symptomatic and precise identification of lung cancer, providing a vital tool for improving survival rates and reducing diagnostic errors.
LENA Molecular Dx Leukemia Platform
Breakthrough technology of Alercell-Oncology.
Alercell is now a One-Stop-Shop for all Leukemia tests.
Alercell Management
Alercell Management
Alercell Management
Alercell Management
Frederic Scheer
CEO
Prof. Gleb Sukhorukov
CTO- Nanoparticles Theranostics Queen’s Mary University - London
Michael Okada
CFO
Alex Scheer MD
CMO - Memorial Sloan Kettering
Pradeep Albert, MD
Ex VP Strategy for Infectious and Diagnostics
Donna Mendes ,MD
Ex VP core-laboratory diagnostics Mount Sinai Hospital NYC
Dr. Elina Tsyvkin, MD
Ex. VP Hematology-Leukemia & Molecular Diagnostic Memorial Sloan Kettering
Lawrence Daniels, MD
Neurosurgery
Frederic Scheer
CEO
Prof. Gleb Sukhorukov
CTO- Nanoparticles Theranostics Queen’s Mary University - London
Michael Okada
CFO
Alex Scheer MD
CMO - Memorial Sloan Kettering
Pradeep Albert, MD
Ex VP Strategy for Infectious and Diagnostics
Donna Mendes ,MD
Ex VP core-laboratory diagnostics Mount Sinai Hospital NYC
Dr. Elina Tsyvkin, MD
Ex. VP Hematology-Leukemia & Molecular Diagnostic Memorial Sloan Kettering
Lawrence Daniels, MD
Neurosurgery
Frederic Scheer
CEO
Prof. Gleb Sukhorukov
CTO- Nanoparticles Theranostics Queen’s Mary University - London
Michael Okada
CFO
Alex Scheer MD
CMO - Memorial Sloan Kettering
Pradeep Albert, MD
Ex VP Strategy for Infectious and Diagnostics
Donna Mendes ,MD
Ex VP core-laboratory diagnostics Mount Sinai Hospital NYC
Dr. Elina Tsyvkin, MD
Ex. VP Hematology-Leukemia & Molecular Diagnostic Memorial Sloan Kettering
Lawrence Daniels, MD
Neurosurgery
Frederic Scheer
CEO
Prof. Gleb Sukhorukov
CTO- Nanoparticles Theranostics Queen’s Mary University - London
Michael Okada
CFO
Alex Scheer MD
CMO - Memorial Sloan Kettering
Pradeep Albert, MD
Ex VP Strategy for Infectious and Diagnostics
Donna Mendes ,MD
Ex VP core-laboratory diagnostics Mount Sinai Hospital NYC
Dr. Elina Tsyvkin, MD
Ex. VP Hematology-Leukemia & Molecular Diagnostic Memorial Sloan Kettering
Lawrence Daniels, MD
Neurosurgery
Frederic Scheer
CEO
Prof. Gleb Sukhorukov
CTO- Nanoparticles Theranostics Queen’s Mary University - London
Michael Okada
CFO
Alex Scheer MD
CMO - Memorial Sloan Kettering
Pradeep Albert, MD
Ex VP Strategy for Infectious and Diagnostics
Donna Mendes ,MD
Ex VP core-laboratory diagnostics Mount Sinai Hospital NYC
Dr. Elina Tsyvkin, MD
Ex. VP Hematology-Leukemia & Molecular Diagnostic Memorial Sloan Kettering
Lawrence Daniels, MD
Neurosurgery
Frederic Scheer
CEO
Prof. Gleb Sukhorukov
CTO- Nanoparticles Theranostics Queen’s Mary University - London
Michael Okada
CFO
Alex Scheer MD
CMO - Memorial Sloan Kettering
Pradeep Albert, MD
Ex VP Strategy for Infectious and Diagnostics
Donna Mendes ,MD
Ex VP core-laboratory diagnostics Mount Sinai Hospital NYC
Dr. Elina Tsyvkin, MD
Ex. VP Hematology-Leukemia & Molecular Diagnostic Memorial Sloan Kettering
Lawrence Daniels, MD
Neurosurgery
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy
Alercell
Request A call
+1 406 920 8787
info@alercell.com
Alercell USA
5 West Mendenhall Ste 202
Montana 59715, United States
Hey, are you curious about our early diagnostics or medical kit?
© 2025 — ALERCELL
Privacy